EICHOR
● Enrolling By Invitation
Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C
Condition: Irritable Bowel Syndrome With Constipation (IBS-C) · Sponsor: Ardelyx
About this study
Open-label long-term safety study of tenapanor in pediatric patients with IBS-C.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (27)
| G & L Research, LLC | Foley, Alabama, United States | — |
| Advanced Research Center, Inc. | Anaheim, California, United States | — |
| Prohealth Research Center | Doral, Florida, United States | — |
| I.H.S. Health, LLC | Kissimmee, Florida, United States | — |
| Valencia Medical and Research Center | Miami, Florida, United States | — |
| Orlando Health, Inc.- APH Center for Digestive Health and Nutrition | Orlando, Florida, United States | — |
| Florida Pharmaceutical Research and Associates, Inc. | South Miami, Florida, United States | — |
| OSF Saint Francis Medical Center | Peoria, Illinois, United States | — |
| Riley Children's Health | Indianapolis, Indiana, United States | — |
| Maine Health | Portland, Maine, United States | — |
| Mankato Clinic/ Javara Research Ltd | Mankato, Minnesota, United States | — |
| Boys Town National Research Hospital | Boys Town, Nebraska, United States | — |
+ 15 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05905926